CrossrefInfokarte
Interview for Breast Cancer Management with Dr David Montgomery: Marketing Authorization for Pfizer’s Metastatic Breast Cancer Treatment, Palbociclib (Ibrance®) in Combination with Endocrine Therapy
Breast Cancer Management · 2016
DOI: 10.2217/bmt-2017-0006 ↗Abstract
Kein Abstract verfügbar.
EUVIMED